Navigation Links
Superbug risk to war wounded
Date:3/29/2009

Soldiers who survive severe injuries on battlefields such as those in Iraq and Afghanistan can be at risk from developing infections of their wounds with multidrug resistant bacteria. The potentially lethal microbes include superbugs such as methicillin resistant Staphylococcus aureus (MRSA), Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella species and Escherichia coli.

Dr Clinton K. Murray, from Brooke Army Medical Center, USA, told the Society for General Microbiology Meeting at the International Centre, Harrogate, that at the beginning of the 20th century improved military hygiene and disease control led to a steady decline in the number of wartime deaths attributable to infections classically known as "war pestilence," which included cholera, dysentery, plague, smallpox, typhoid, and typhus fever.

"The development of more effective personal protective equipment, as well as training medics to provide life-saving procedures on the battlefield, has greatly improved survival rates," said Dr Murray. "Positioning surgical and advanced medical care nearer to the point of injury has also enabled casualties to survive near-catastrophic wounds. But even though combat casualties are surviving these severe injuries, they risk developing wound infections. Microbes on the casualty's skin can be introduced into the wound at the time of injury or during subsequent medical care."

Although most of the infections can be treated with standard antibiotics, some of them may be caused by pathogens resistant to many if not all of these drugs. This requires clinicians to prescribe less commonly used antibiotics such as colistin. Modern microbiology and antimicrobial agents can do a lot but hospital infection control even in a war zone is of essential importance.


'/>"/>

Contact: Dianne Stilwell
d.stilwell@sgm.ac.uk
07-957-200-214
Society for General Microbiology
Source:Eurekalert

Page: 1

Related medicine news :

1. Are Hospital Mobile Phones Dialing Up Superbugs?
2. Engineered Viruses Could Battle Superbugs
3. No ESKAPE! New drugs against MRSA, other superbugs still lacking
4. Superbugs on the rise in Canadian hospitals, new Queens study shows
5. Superbug breast infections controllable in nursing mothers, UT Southwestern researchers find
6. Steno Superbug Genome Shows Extreme Drug Resistance
7. Superbug genome sequenced
8. Green Tea Boosts Antibiotics for Superbugs
9. Scientists uncover how superbug Staph aureus resists our natural defenses
10. Some Facelift Patients Infected With MRSA Superbug
11. Scientists strike blow in superbugs struggle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... ... May 30, 2016 , ... "This ... FCPX," said Christina Austin - CEO of Pixel Film Studios. , TransPack ... Cut Pro X. Choose from abstract transitions to more simple wipes with blur ...
(Date:5/29/2016)... ... 2016 , ... Whole Health Supply is happy to announce the favorable reception ... Amazon.com. This new style of nail clipper has a wider jaw opening that is ... and the actual handle is 2.5mm thick to accommodate the cutting force. This is ...
(Date:5/28/2016)... ... May 28, 2016 , ... "Color Grading media can be ... a preset onto their media," said Christina Austin - CEO of Pixel Film Studios. ... quickly and easily add stylish color grades to their footage. A LUT is a ...
(Date:5/27/2016)... , ... May 27, 2016 , ... More than a ... it is not surprising that bariatric surgery has received increased attention in recent years, ... Of course, when it comes to weight loss, most people are familiar with the ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... An influential ... for a third time to shed lights on the variety of topics detailing why ... stories, “Nurse Appreciation” tackles why this career has gone from being in a major ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharmaceutical company focused on late-stage drug development, ... Dexcel Pharma of pivotal batches required for ... Drug Administration (FDA). This follows Kitov,s announcement ... III trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... 2016 TARE (Transarterial Radio-embolization) ... Savings and Overall Decreased Use of Hospital ... international specialist healthcare company, has today announced the ... Meeting of ISPOR (International Society for Pharmacoeconomics and ... (HCC) using yttrium-90 glass microspheres is associated with ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 ... bedient dringenden Bedarf zur ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... und Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur Entwicklung ... zu sein. Ein erstes Projekt wird die Entwicklung ...
Breaking Medicine Technology: